<!DOCTYPE html>
        <html lang="en">
        <head>
          <meta charset="UTF-8" />
          <meta name="viewport" content="width=device-width, initial-scale=1.0" />
          <title>MinMaxMuscle | Semax</title>
          <meta name="description" content="Curated source summaries for Semax." />
          <link rel="stylesheet" href="../assets/css/style.css" />
        </head>
        <body>
          <header>
            <div class="nav-container">
              <div class="logo">
                <img src="../assets/img/logo.png" alt="MinMaxMuscle Logo" />
                <span>MINMAXMUSCLE</span>
              </div>
              <nav class="desktop-nav">
                <a href="../index.html">Home</a>
                <a href="../training.html">Training</a>
                <a href="../nutrition.html">Nutrition</a>
                <a href="../peptidesdb.html">Peptides</a>
                <a href="../coaching.html">Coaching</a>
                <a href="https://blog.minmaxmuscle.com">Blog</a>
                <a href="https://blog.minmaxmuscle.com/forum">Forums</a>
                <a href="../contact.html">Contact</a>
              </nav>
              <div class="hamburger" id="hamburger">
                <span></span>
                <span></span>
                <span></span>
              </div>
            </div>
            <div class="mobile-menu" id="mobileMenu">
              <a href="../index.html">Home</a>
              <a href="../training.html">Training</a>
              <a href="../nutrition.html">Nutrition</a>
              <a href="../peptidesdb.html">Peptides</a>
              <a href="../coaching.html">Coaching</a>
              <a href="https://blog.minmaxmuscle.com">Blog</a>
              <a href="https://blog.minmaxmuscle.com/forum">Forums</a>
              <a href="../contact.html">Contact</a>
            </div>
          </header>
          <main>
            <section class="hero">
              <h1>Semax</h1>
              <p>Automated source summaries for educational review. Verify claims with qualified professionals.</p>
            </section>
            <section class="peptide-source">
  <h2>Source</h2>
  <p><a href="https://en.wikipedia.org/wiki/Semax" rel="noopener noreferrer" target="_blank">https://en.wikipedia.org/wiki/Semax</a></p>
  <ul>
    <li>Main page</li><li>Contents</li><li>Current events</li><li>Random article</li><li>About Wikipedia</li><li>Contact us</li><li>Help</li><li>Learn to edit</li><li>Community portal</li><li>Recent changes</li><li>Upload file</li><li>Special pages</li><li>Donate</li><li>Create account</li><li>Log in</li><li># Contents</li><li>(Top)</li><li>1 Medical uses</li><li>2.1 Pharmacodynamics</li><li>2.2 Pharmacokinetics</li><li>3 Chemistry</li><li>4 History</li><li>5.1 Etymology</li><li>6 See also</li><li>7 References</li><li># Semax</li><li>Deutsch</li><li>Español</li><li>עברית</li><li>Русский</li><li>Српски / srpski</li><li>Srpskohrvatski / српскохрватски</li><li>Article</li><li>Talk</li><li>Read</li><li>Edit</li><li>View history</li><li>What links here</li><li>Related changes</li><li>Permanent link</li><li>Page information</li><li>Cite this page</li><li>Get shortened URL</li><li>Download QR code</li><li>Download as PDF</li><li>Printable version</li><li>Wikidata item</li><li>N06BX</li><li>US : Not FDA approved; unscheduled</li><li>(2 S )-1-[2-{[(2 S )-1-[(2 S )-2-{[2-{[(2 S )-2-{[(2 S )-2-amino-4-methylsulfanylbutanoyl]amino}-4-carboxybutanoyl]amino}-3-(1 H -imidazol-5-yl)propanoyl]amino}-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino}acetyl]pyrrolidine-2-carboxylic acid</li><li>80714-61-0 Y 4037-01-8</li><li>122178</li><li>108969</li><li>I5FAL2585H</li><li>DTXSID601001439</li><li>Interactive image</li><li>O=C(N[C@@H](CCC(O)=O)C(N[C@@H](CC1=CNC=N1)C(N[C@@H](CC2=CC=CC=C2)C(N3[C@@H](CCC3)C(NCC(N4[C@@H](CCC4)C(O)=O)=O)=O)=O)=O)=O)[C@H](CCSC)N</li><li>InChI=1S/C37H51N9O10S/c1-57-16-13-24(38)32(50)42-25(11-12-31(48)49)33(51)43-26(18-23-19-39-21-41-23)34(52)44-27(17-22-7-3-2-4-8-22)36(54)46-15-5-9-28(46)35(53)40-20-30(47)45-14-6-10-29(45)37(55)56/h2-4,7-8,19,21,24-29H,5-6,9-18,20,38H2,1H3,(H,39,41)(H,40,53)(H,42,50)(H,43,51)(H,44,52)(H,48,49)(H,55,56)/t24-,25-,26?,27-,28-,29-/m0/s1</li><li>Key:AFEHBIGDWIGTEH-CXFOGXNKSA-N</li><li>Semax is a medication which is used in Eastern Europe for the treatment of a broad range of conditions like brain trauma but predominantly for its claimed nootropic , neuroprotective , and neurorestorative effects. [ 1 ]</li><li>The mechanism of action of Semax is unknown. [ 2 ] [ 3 ] It might interact with certain melanocortin receptors or inhibit enkephalinase enzymes . [ 2 ] [ 3 ] Chemically, Semax is a peptide and a synthetic analogue of a fragment of adrenocorticotropic hormone (ACTH). [ 4 ] [ 5 ]</li><li>Semax was first described by 1991. [ 5 ] Although used as a prescription drug in Russia , Semax has not been evaluated, approved for use, or marketed in most other countries. [ 6 ] [ 7 ] The drug is widely sold by online vendors and used as a purported nootropic (cognitive enhancer). [ 1 ] [ 8 ]</li><li># Medical uses</li><li>Semax [ 9 ] has undergone extensive study in Russia and is on the Russian List of Vital & Essential Drugs approved by the Russian Federation government on 7 December 2011. [ 10 ] Medical uses for Semax include treatment of stroke , transient ischemic attack , memory and cognitive disorders , peptic ulcers , optic nerve disease , and to boost the immune system . [ 11 ] [ 12 ] [ 13 ] [ 14 ]</li><li># Pharmacology</li><li># Pharmacodynamics</li><li>In animals, Semax rapidly elevates the levels and expression of brain-derived neurotrophic factor (BDNF) and its signaling receptor tropomyosin receptor kinase B (TrkB) in the hippocampus , [ 15 ] and rapidly activates serotonergic and dopaminergic brain systems. [ 16 ] [ 17 ] Accordingly, it has been found to produce antidepressant -like and anxiolytic -like effects, [ 18 ] [ 19 ] attenuate the behavioral effects of exposure to chronic stress , [ 18 ] [ 19 ] and potentiate the locomotor activity produced by D -amphetamine . [ 17 ] [ 20 ] As such, it has been suggested that Semax may be effective in the treatment of depression . [ 21 ]</li><li>Though the exact mechanism of action of Semax is unclear, there is evidence that it may act through melanocortin receptors . Specifically, there is a report of Semax competitively antagonizing the action of α-melanocyte-stimulating hormone (α-MSH) at the MC 4 and MC 5 receptors in both in vitro and in vivo experimental conditions, indicating that it may act as an antagonist or partial agonist of these receptors. (&alpha-MSH acts as a full agonist of all five melanocortin receptors). [ 2 ] Semax did not antagonize α-MSH at the MC 3 receptor , though this receptor could still be a target of the drug. [ 2 ] As for the MC 1 and MC 2 receptors , they were not assayed. [ 2 ]</li><li>In addition to actions at receptors, Semax, as well as a related peptide drug, Selank , have been found to inhibit enzymes involved in the degradation of enkephalins and other endogenous regulatory peptides ( IC 50 = 10 μM), though the clinical significance of this property is uncertain. [ 3 ]</li><li># Pharmacokinetics</li><li>As a peptide, Semax has poor oral bioavailability and hence is administered parenterally as a nasal spray or subcutaneous injection.</li><li># Chemistry</li><li>Semax is a heptapeptide and synthetic analogue of a fragment of adrenocorticotropic hormone (ACTH), ACTH (4-10), of the following amino acid sequence : Met-Glu-His-Phe-Pro-Gly-Pro ( .mw-parser-output .monospaced{font-family:monospace,monospace} MEHFPGP in single-letter form). [ 4 ]</li><li># History</li><li>Semax was first described in scientific literature by 1991. [ 5 ]</li><li># Society and culture</li><li># Etymology</li><li>Semax is composed of seven amino acid residues: Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP), which is reflected in the name - from an abbreviation of "seven amino acids"—in Russian: СЕМь АминоКиСлот—СЕМАКС.</li><li># See also</li><li>Selank</li><li>Adamax</li><li>9-Methyl-β-carboline (9-Me-BC)</li><li>Bromantane</li><li>List of Russian drugs</li><li># References</li><li>^ a b .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#bf3c2c)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#bf3c2c)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}} Voronina TA (2023). "Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects" . Neurochemical Journal . 17 (2): 180– 188. doi : 10.1134/S1819712423020198 . ISSN 1819-7124 .</li><li>^ a b c d e Bertolini A (March 2012). "Drug-induced activation of the nervous control of inflammation: a novel possibility for the treatment of hypoxic damage". European Journal of Pharmacology . 679 ( 1– 3): 1– 8. doi : 10.1016/j.ejphar.2012.01.004 . PMID 22293371 .</li><li>^ a b c Kost NV, Sokolov OI, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, et al. (2001). "Semax and selank inhibit the enkephalin-degrading enzymes from human serum". Bioorganicheskaia Khimiia (in Russian). 27 (3): 180– 183. doi : 10.1023/A:1011373002885 . PMID 11443939 . S2CID 26029820 .</li><li>^ a b Deigin VI, Poluektova EA, Beniashvili AG, Kozin SA, Poluektov YM (March 2022). "Development of Peptide Biopharmaceuticals in Russia" . Pharmaceutics . 14 (4): 716. doi : 10.3390/pharmaceutics14040716 . PMC 9030433 . PMID 35456550 .</li><li>^ a b c Potaman VN, Alfeeva LY, Kamensky AA, Levitzkaya NG, Nezavibatko VN (April 1991). "N-terminal degradation of ACTH(4-10) and its synthetic analog semax by the rat blood enzymes". Biochemical and Biophysical Research Communications . 176 (2): 741– 746. Bibcode : 1991BBRC..176..741P . doi : 10.1016/S0006-291X(05)80247-5 . PMID 1851003 .</li><li>^ "Home" . AdisInsight . Retrieved 3 September 2024 .</li><li>^ "Semax - Search Results - PubMed" . PubMed . Retrieved 12 November 2023 .</li><li>^ Jędrejko K, Catlin O, Stewart T, Anderson A, Muszyńska B, Catlin DH (August 2023). "Unauthorized ingredients in "nootropic" dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents" . Drug Testing and Analysis . 15 (8). Wiley: 803– 839. doi : 10.1002/dta.3529 . PMID 37357012 .</li><li>^ "ПЕРЕЧЕНЬ. жизненно необходимых и важнейших лекарственных препаратов на 2012 год. (Vital and Essential Drugs List, 2012) - Russian Federation" . World Health Organization. 2012. Archived from the original on 2 February 2015.</li><li>^ "Semax" . Institute of Molecular Genetics, Russian Academy of Sciences. Archived from the original on 25 March 2013 . Retrieved 6 October 2012 .</li><li>^ Kurysheva NI, Shpak AA, Ioĭleva EE, Galanter LI, Nagornova ND, Shubina NI, et al. (2001). "[Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone]". Vestnik Oftalmologii . 117 (4): 5– 8. PMID 11569188 .</li><li>^ Ivanikov IO, Brekhova ME, Samonina GE, Myasoedov NF, Ashmarin IP (July 2002). "Therapy of peptic ulcer with semax peptide". Bulletin of Experimental Biology and Medicine . 134 (1): 73– 74. doi : 10.1023/A:1020621124776 . PMID 12459874 . S2CID 23447014 .</li><li>^ Korneev EA, Kazakova TB (1999). "Current approaches to the analysis of the effects of stress on metabolic processes in cells of the nervous and immune systems". Med. Immunology . 1 ( 1– 2): 17– 22.</li><li>^ Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J, et al. (October 2006). "Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus". Brain Research . 1117 (1): 54– 60. doi : 10.1016/j.brainres.2006.07.108 . PMID 16996037 . S2CID 27592503 .</li><li>^ Eremin KO, Kudrin VS, Grivennikov IA, Miasoedov NF, Rayevsky KS (2004). "Effects of Semax on dopaminergic and serotoninergic systems of the brain". Doklady Biological Sciences . 394 ( 1– 6): 1– 3. doi : 10.1023/b:dobs.0000017114.24474.40 . PMID 15088389 . S2CID 12955434 .</li><li>^ a b Eremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, et al. (December 2005). "Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents". Neurochemical Research . 30 (12): 1493– 1500. doi : 10.1007/s11064-005-8826-8 . PMID 16362768 . S2CID 38202287 .</li><li>^ a b Vilenskiĭ DA, Levitskaia NG, Andreeva LA, Alfeeva LI, Kamenskiĭ AA, Miasoedov NF (June 2007). "[Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats]". Rossiiskii Fiziologicheskii Zhurnal imeni I.M. Sechenova (in Russian). 93 (6): 661– 669. PMID 17850024 .</li><li>^ a b Yatsenko KA, Glazova NY, Inozemtseva LS, Andreeva LA, Kamensky AA, Grivennikov IA, et al. (November 2013). "Heptapeptide semax attenuates the effects of chronic unpredictable stress in rats". Doklady Biological Sciences . 453 : 353– 357. doi : 10.1134/S0012496613060161 . PMID 24385169 . S2CID 9699654 .</li><li>^ Volodina MA, Sebentsova EA, Glazova NY, Levitskaya NG, Andreeva LA, Manchenko DM, et al. (March 2012). "Semax attenuates the influence of neonatal maternal deprivation on the behavior of adolescent white rats". Bulletin of Experimental Biology and Medicine . 152 (5): 560– 563. doi : 10.1007/s10517-012-1574-2 . PMID 22803132 . S2CID 1419653 .</li><li>^ Pae CU (January 2008). "Therapeutic possibility of "Semax" for depression" . CNS Spectrums . 13 (1): 20– 21. doi : 10.1017/S1092852900016102 . PMID 18204410 .</li><li>v</li><li>t</li><li>e</li><li>Agonists: ACTH (corticotropin)</li><li>Afamelanotide (melanotan I)</li><li>BMS-470539</li><li>Bremelanotide</li><li>HS-014</li><li>HS-024</li><li>MSH ( α , β , γ )</li><li>Melanotan II</li><li>Modimelanotide</li><li>PL-8177</li><li>SHU-8914</li><li>SHU-9005</li><li>SHU-9119</li><li>SNAP-7941</li><li>Antagonists: ASIP</li><li>Alsactide</li><li>Codactide</li><li>Giractide</li><li>Norleusactide (pentacosactride)</li><li>Seractide</li><li>Tetracosactide (tetracosactrin, cosyntropin)</li><li>Tosactide (octacosactrin)</li><li>Tricosactide</li><li>Tridecactide</li><li>Antagonists: Atumelnant (CRN04894)</li><li>PG-931</li><li>Antagonists: AGRP</li><li>ASIP</li><li>Mifomelatide (TCMCB07)</li><li>ML-00253764</li><li>PG-106</li><li>AZD2820</li><li>BIM-22493</li><li>Bivamelagon (LB54640)</li><li>LY-2112688</li><li>MK-0493</li><li>PF-00446687</li><li>PL-6983</li><li>Ro 27-3225</li><li>Setmelanotide</li><li>THIQ</li><li>HS-131</li><li>JKC-363</li><li>MCL-0020</li><li>MCL-0042</li><li>MCL-0129</li><li>MPB-10</li><li>Unknown: Semax</li><li>Agonists: Alsactide</li><li>Dersimelagon</li><li>Propeptides: Lipotropin ( β , γ )</li><li>N-POMC (NPP, pro-γ-MSH)</li><li>Proopiomelanocortin (POMC)</li><li>3-HO-PCP</li><li>7-Acetoxymitragynine</li><li>7-Hydroxymitragynine</li><li>ψ-Akuammigine</li><li>α-Chlornaltrexamine</li><li>α-Narcotine</li><li>Acetyldihydrocodeine</li><li>Acetylfentanyl</li><li>Acrylfentanyl</li><li>Adrenorphin (metorphamide)</li><li>AH-7921</li><li>Akuammicine</li><li>Akuammidine</li><li>Alfentanil</li><li>Anileridine</li><li>Apparicine</li><li>β-Endorphin</li><li>BAM-12P</li><li>BAM-18P</li><li>BAM-22P</li><li>Benzhydrocodone</li><li>Benzylmorphine</li><li>Bezitramide</li><li>Biphalin</li><li>BU08070</li><li>Buprenorphine</li><li>Butorphan</li><li>Butorphanol</li><li>Butyrfentanyl</li><li>BW373U86</li><li>Carfentanil</li><li>Casokefamide</li><li>Cebranopadol</li><li>Chloroxymorphamine</li><li>Codeine</li><li>DADLE</li><li>DAMGO (DAGO)</li><li>Dermorphin</li><li>Desmetramadol (desmethyltramadol)</li><li>Desomorphine</li><li>Deumitragynine</li><li>Dextromoramide</li><li>Dextropropoxyphene (propoxyphene)</li><li>Dezocine</li><li>Dimenoxadol</li><li>Dimethylaminopivalophenone</li><li>Eluxadoline</li><li>Diamorphine (heroin)</li><li>Dihydrocodeine</li><li>Dihydroetorphine</li><li>Dihydromorphine</li><li>Dinalbuphine sebacate</li><li>Diphenoxylate</li><li>Dipipanone</li><li>Dynorphin A</li><li>Embutramide</li><li>Endomorphin-1</li><li>Endomorphin-2</li><li>Eseroline</li><li>Ethylmorphine</li><li>Etorphine</li><li>Fentanyl</li><li>Fluorophen</li><li>Frakefamide</li><li>Furanylfentanyl</li><li>Hemorphin-4</li><li>Herkinorin</li><li>Hodgkinsine</li><li>Hydrocodone</li><li>Hydromorphinol</li><li>Hydromorphone</li><li>IBNtxA</li><li>Ketamine</li><li>Ketobemidone</li><li>Kratom</li><li>Laudanosine</li><li>Lefetamine</li><li>Leu-enkephalin</li><li>Levacetylmethadol</li><li>Levomethorphan</li><li>Levorphanol</li><li>Lexanopadol</li><li>Loperamide</li><li>Loxicodegol</li><li>LS-115509</li><li>Matrine</li><li>MEB-1170</li><li>Meptazinol</li><li>Met-enkephalin (metenkefalin)</li><li>Methadone</li><li>Metkefamide</li><li>Metopon</li><li>Mitragynine</li><li>Mitragynine pseudoindoxyl</li><li>Morphiceptin</li><li>Morphine</li><li>Nalbuphine</li><li>Naloxone benzoylhydrazone (NalBzOH)</li><li>Nalmexone</li><li>Naltalimide</li><li>Neopine</li><li>NFEPP</li><li>Nicocodeine</li><li>Nicodicodine</li><li>Nicomorphine</li><li>Norketamine</li><li>Nufenoxole</li><li>Octreotide</li><li>Oliceridine</li><li>Oxycodegol (NKTR-181)</li><li>Oxymorphone-3-methoxynaltrexonazine (OM-3-MNZ)</li><li>Oripavine</li><li>Oxycodone</li><li>Oxymorphazone</li><li>Oxymorphonazine</li><li>Oxymorphone</li><li>Oxymorphone phenylhydrazone</li><li>OxyPNPH</li><li>Papaver somniferum ( opium )</li><li>Pentazocine</li><li>Pericine</li><li>Pethidine (meperidine)</li><li>Phenazocine</li><li>Phencyclidine</li><li>Piminodine</li><li>Piritramide</li><li>PL-017</li><li>Prodine</li><li>Propiram</li><li>PZM21</li><li>Racemethorphan</li><li>Racemorphan</li><li>Remifentanil</li><li>Salsolinol</li><li>SC-17599</li><li>Sinomenine</li><li>SR-17018</li><li>Sufentanil</li><li>Tapentadol</li><li>Tetrahydropapaveroline</li><li>TH-030418</li><li>Thebaine</li><li>Thienorphine</li><li>Tianeptine</li><li>Tilidine</li><li>Tramadol</li><li>Trimebutine</li><li>TRIMU 5</li><li>TRV734</li><li>Tubotaiwine</li><li>U-47700</li><li>Valorphin</li><li>Viminol</li><li>Xorphanol</li><li>(3S,4S)-Picenadol</li><li>2-(S)-N,N-(R)-Viminol</li><li>3CS-nalmefene</li><li>4-Caffeoyl-1,5-quinide</li><li>4′-Hydroxyflavanone</li><li>4',7-Dihydroxyflavone</li><li>6β-Naltrexol</li><li>6β-Naltrexol-d4</li><li>18-MC</li><li>α-Gliadin</li><li>β-Chlornaltrexamine</li><li>β-Funaltrexamine</li><li>Akuammine</li><li>Alvimopan</li><li>AM-251</li><li>Apigenin</li><li>AT-076</li><li>Axelopran</li><li>Bevenopran</li><li>Catechin</li><li>Catechin gallate</li><li>Clocinnamox</li><li>CTAP</li><li>CTOP</li><li>Cyclofoxy</li><li>Cyprodime</li><li>Diacetylnalorphine</li><li>Diprenorphine</li><li>ECG</li><li>EGC</li><li>Epicatechin</li><li>Eptazocine</li><li>Gemazocine</li><li>Ginsenoside R</li><li>Hyperoside</li><li>Ibogaine</li><li>JDTic</li><li>Levallorphan</li><li>Lobeline</li><li>LY-255582</li><li>LY-2196044</li><li>Methocinnamox</li><li>Methylnaltrexone</li><li>Methylsamidorphan chloride</li><li>Naldemedine</li><li>Nalmefene</li><li>Nalodeine (N-allylnorcodeine)</li><li>Nalorphine</li><li>Nalorphine dinicotinate</li><li>Naloxazone</li><li>Naloxegol</li><li>Naloxol</li><li>Naloxonazine</li><li>Naloxone</li><li>Naltrexazone</li><li>Naltrexonazine</li><li>Naltrexone</li><li>Naltrindole</li><li>Naringenin</li><li>Noribogaine</li><li>Oxilorphan</li><li>Pawhuskin A</li><li>Rimonabant</li><li>Quadazocine</li><li>Samidorphan</li><li>Taxifolin</li><li>6'-GNTI</li><li>7-SIOM</li><li>ADL-5747 (PF-04856881)</li><li>ADL-5859</li><li>Alazocine (SKF-10047)</li><li>Amoxapine</li><li>AR-M100390 (ARM390)</li><li>AZD2327</li><li>BU-48</li><li>Cyclazocine</li><li>Deltorphin A</li><li>Deltorphin I</li><li>Deltorphin II</li><li>Desmethylclozapine</li><li>DPDPE</li><li>DPI-221</li><li>DPI-3290</li><li>DSLET</li><li>Ethylketazocine</li><li>FIT</li><li>Isomethadone</li><li>JNJ-20788560</li><li>KNT-127</li><li>Lofentanil</li><li>Metazocine</li><li>N-Phenethyl-14-ethoxymetopon</li><li>Norbuprenorphine</li><li>NalBzOH</li><li>Proglumide</li><li>RWJ-394674</li><li>SB-235863</li><li>SNC-80</li><li>SNC-162</li><li>TAN-67 (SB-205,607)</li><li>Thiobromadol (C-8813)</li><li>Tonazocine</li><li>TRV250</li><li>Zenazocine</li><li>5'-NTII</li><li>α-Santolol</li><li>BNTX</li><li>ICI-154129</li><li>ICI-174864</li><li>Methylnaltrindole</li><li>N-Benzylnaltrindole</li><li>Naltriben</li><li>SDM25N</li><li>SoRI-9409</li><li>8-CAC</li><li>14-Methoxymetopon</li><li>Allomatrine</li><li>Apadoline</li><li>Asimadoline</li><li>Big dynorphin</li><li>Bremazocine</li><li>BRL-52537</li><li>Ciprefadol</li><li>CR665</li><li>Cyclorphan</li><li>Cyprenorphine</li><li>Difelikefalin</li><li>Dynorphin B (rimorphin)</li><li>Enadoline</li><li>Erinacine E</li><li>Fedotozine</li><li>GR-89696</li><li>GR-103545</li><li>HS665</li><li>HZ-2</li><li>ICI-199,441</li><li>ICI-204,448</li><li>Ketazocine</li><li>Leumorphin (dynorphin B-29)</li><li>LPK-26</li><li>Lufuradom</li><li>MB-1C-OH</li><li>Menthol</li><li>Mianserin</li><li>Mirtazapine</li><li>Moxazocine</li><li>MR-2034</li><li>N-MPPP</li><li>Nalfurafine</li><li>Niravoline</li><li>Norbuprenorphine-3-glucuronide</li><li>Oxa-noribogaine</li><li>Proxorphan</li><li>RB-64</li><li>Salvinorin A ( salvia )</li><li>Salvinorin B ethoxymethyl ether</li><li>Salvinorin B methoxymethyl ether</li><li>Spiradoline (U-62066)</li><li>Tifluadom</li><li>Tricyclic antidepressants (e.g., amitriptyline , desipramine , imipramine , nortriptyline )</li><li>U-50488</li><li>U-54494A</li><li>U-69593</li><li>5'-GNTI</li><li>Buprenorphine/samidorphan</li><li>Amentoflavone</li><li>ANTI</li><li>Arodyne</li><li>Aticaprant</li><li>AZ-MTAB</li><li>Binaltorphimine</li><li>BU09059</li><li>CERC-501 (LY-2456302)</li><li>CVL-354</li><li>DIPPA</li><li>LY-2444296</li><li>LY-2459989</li><li>LY-2795050</li><li>MeJDTic</li><li>ML190</li><li>ML350</li><li>MR-2266</li><li>N-Fluoropropyl-JDTic</li><li>Navacaprant</li><li>Norbinaltorphimine</li><li>PF-4455242</li><li>UPHIT</li><li>Zyklophin</li><li>(Arg14,Lys15)Nociceptin</li><li>((pF)Phe 4 )Nociceptin(1-13)NH 2</li><li>(Phe 1 Ψ(CH 2 -NH)Gly 2 )Nociceptin(1-13)NH 2</li><li>Ac-RYYRWK-NH 2</li><li>Ac-RYYRIK-NH 2</li><li>JNJ-19385899</li><li>MCOPPB</li><li>MT-7716</li><li>NNC 63-0532</li><li>Nociceptin (orphanin FQ)</li><li>Nociceptin (1-11)</li><li>Nociceptin (1-13)NH 2</li><li>Ro64-6198</li><li>Ro65-6570</li><li>SCH-221510</li><li>SCH-486757</li><li>SR-8993</li><li>SR-16435</li><li>Sunobinop (S-117957)</li><li>(Nphe 1 )Nociceptin(1-13)NH 2</li><li>BAN-ORL-24</li><li>BTRX-246040 (LY-2940094)</li><li>J-113397</li><li>JTC-801</li><li>Nociceptin (1-7)</li><li>Nocistatin</li><li>SB-612111</li><li>SR-16430</li><li>Trap-101</li><li>UFP-101</li><li>Enkephalinase inhibitors : Amastatin</li><li>BL-2401</li><li>Candoxatril</li><li>D -Phenylalanine</li><li>Dexecadotril (retorphan)</li><li>Ecadotril (sinorphan)</li><li>Kelatorphan</li><li>Racecadotril (acetorphan)</li><li>RB-101</li><li>RB-120</li><li>RB-3007</li><li>Opiorphan</li><li>Semax</li><li>Spinorphin</li><li>Thiorphan</li><li>Tynorphin</li><li>Ubenimex (bestatin)</li><li>Propeptides: β-Lipotropin (proendorphin)</li><li>Prodynorphin</li><li>Proenkephalin</li><li>Pronociceptin</li><li>Others: Kyotorphin (met-enkephalin releaser/degradation stabilizer)</li><li>Drugs with unknown mechanisms of action</li><li>Enkephalinase inhibitors</li><li>Melanocortin receptor antagonists</li><li>Neuroprotective agents</li><li>Nootropics</li><li>Heptapeptides</li><li>Russian drugs</li><li>Peptide therapeutics</li><li>Drugs in the Soviet Union</li><li>CS1 Russian-language sources (ru)</li><li>Articles with short description</li><li>Short description matches Wikidata</li><li>Use dmy dates from July 2025</li><li>Short description is different from Wikidata</li><li>Drugs with non-standard legal status</li><li>Articles without EBI source</li><li>Chemical pages without DrugBank identifier</li><li>Articles without KEGG source</li><li>Articles containing unverified chemical infoboxes</li><li>This page was last edited on 19 January 2026, at 06:37 (UTC) .</li><li>Text is available under the Creative Commons Attribution-ShareAlike 4.0 License ; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy . Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. , a non-profit organization.</li><li>Privacy policy</li><li>Disclaimers</li><li>Contact Wikipedia</li><li>Legal & safety contacts</li><li>Code of Conduct</li><li>Developers</li><li>Statistics</li><li>Cookie statement</li><li>Mobile view</li>
  </ul>
</section>
<section class="peptide-source">
  <h2>Source</h2>
  <p><a href="https://pubchem.ncbi.nlm.nih.gov/compound/Semax" rel="noopener noreferrer" target="_blank">https://pubchem.ncbi.nlm.nih.gov/compound/Semax</a></p>
  <ul>
    <li># JavaScript is required...</li><li>Please enable Javascript in order to use PubChem website.</li>
  </ul>
</section>
<section class="peptide-source">
  <h2>Source</h2>
  <p><a href="https://pubmed.ncbi.nlm.nih.gov/15896053/" rel="noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/15896053/</a></p>
  <ul>
    <li># Tuning the surface hydrophobicity of polymer/nanoparticle composite films in the Wenzel regime by composition</li><li># Authors</li><li># Affiliation</li><li>1 Chemistry Department, Koç University, Sariyer Istanbul 34450, Turkey.</li><li>PMID: 15896053</li><li>DOI: 10.1021/la050033y</li><li># Abstract</li><li>Surface hydrophobicity of composite films containing polymer and nanoparticles has been studied as a function of composition. We show that the hydrophobicity can be tuned by adjusting the amount of particles in the two-component system. A sharp transition from a polymer-rich surface to a nanoparticles-rich surface was observed with increasing mass fraction of particles in spin-coated thin films. Water drops on the films did not slide down even at tilt angles of 90 degrees . Contact angle hysteresis increased with the mass fraction of particles indicating that the surface roughness increased as the surfaces remained in the Wenzel regime. Contact angle hysteresis data were quantitatively consistent with predictions of a recent theory.</li>
  </ul>
</section>
            <p class="disclaimer-link"><small>Back to the main peptide list: <a href="../peptidesdb.html">Peptides Overview</a>.</small></p>
          </main>
          <footer>
            © MinMaxMuscle. Discipline builds the body. Systems keep it.
          </footer>
          <script src="../assets/js/script.js"></script>
        </body>
        </html>